No title
Prostate cancer is one of the most prevalent cancer diagnoses for men and is believed to increase in the future due to an aging global population. The 5-year survival rate decreases drastically for metastatic disease, which is currently incurable. Androgens drive prostate cancer via the AR-signaling pathway. For metastatic disease, antiandrogen therapy, external beam therapy, chemotherapy, or ther
